TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
FBIO

Fortress Biotech Inc

Healthcare · Biotechnology

2.00$ -1.9% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Fortress Biotech Inc (FBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 317 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet FBIO
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
145 171 212 250 245 246 265 237 225 141 201 227 222 226 229 269 296 333 391 418 408 397 408 364 324 294 264 181 151 168 165 146 127 144 178 160 181 186 357 317
99 110 152 190 184 183 200 172 160 111 137 164 166 156 159 200 238 266 318 320 301 346 341 299 258 230 202 128 98 117 117 103 86 90 127 110 119 124 295 246
83 88 134 144 111 114 124 99 96 66 116 149 135 137 136 183 218 233 290 275 253 306 288 249 208 178 152 87 75 81 86 76 59 57 91 74 86 79 256 197
86 92 136 169 157 131 166 138 125 83 121 154 140 137 136 183 218 233 290 275 253 306 288 249 208 178 152 87 75 81 86 76 59 57 91 74 86 79 256 197
6.6 5.2 4.2 6.1 14 15 17 17 17 5.5 10 5.0 6.4 14 18 11 16 25 20 27 33 24 32 29 29 28 28 17 8.2 15 10 11 11 10 18 16 18 30 26 37
0.1 0.2 0.2 0.3 0.3 0.2 0.2 0.3 0.7 0.7 0.6 0.7 0.9 0.9 0.8 1.2 1.1 1.4 2.3 14 12 9.9 16 16 15 14 13 12 11 10 11 9.7 12 14 12 13 12 9.6 9.3 8.2
7.0 7.4 7.4 7.3 8.2 9.5 12 14 15 12 12 12 34 12 13 12 12 32 12 33 14 34 14 14 0.0 – 12 7.2 – – – – – – – – – – – –
22 19 19 19 19 19 19 19 19 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
1.6 17 17 17 16 15 14 14 14 1.4 1.2 1.0 7.7 7.4 7.0 6.7 11 15 14 14 13 13 30 29 28 27 26 22 21 20 19 19 18 32 31 30 29 28 26 26
71 88 86 99 124 125 158 141 140 121 150 137 147 154 153 152 120 136 147 170 195 171 214 216 222 244 244 197 164 166 169 160 140 146 146 123 116 123 155 111
39 57 53 53 68 67 79 62 71 56 49 36 47 46 52 57 37 52 54 71 103 101 103 105 106 128 129 129 97 85 88 76 70 71 74 58 54 50 103 62
25 2.0 5.3 6.2 13 13 13 11 20 19 12 13 19 9.0 16 24 1.7 6.4 7.3 5.9 17 7.4 9.5 9.6 11 13 10 18 9.2 5.5 9.6 5.5 3.8 3.2 4.0 5.9 7.8 2.1 4.7 7.2
13 14 13 12 32 18 45 38 37 18 17 9.5 9.1 10 8.3 11 11 11 11 14 43 47 45 54 56 57 66 49 45 35 42 38 34 32 28 20 19 14 14 12
27 26 28 41 51 53 73 73 65 60 74 74 73 82 76 69 55 59 58 59 46 47 89 89 93 93 91 47 46 61 61 67 52 58 56 50 48 60 37 35
37 38 48 72 37 53 42 44 38 1.9 21 32 26 26 37 60 97 100 106 108 93 109 98 77 62 42 38 19 17 23 23 18 21 23 22 44 56 50 162 164
-228 -245 -257 -275 -302 -312 -333 -355 -371 -396 -395 -408 -421 -436 -449 -462 -477 -483 -492 -495 -516 -547 -563 -585 -607 -634 -656 -681 -686 -695 -710 -721 -734 -741 -751 -736 -730 -734 -624 -624
2.7 2.7 2.7 2.7 2.7 2.7 2.8 2.9 3.0 2.9 4.3 3.6 3.8 4.0 4.2 4.6 5.1 5.3 5.4 5.4 5.4 5.6 5.8 5.9 6.0 6.0 6.8 7.4 7.5 7.8 17 18 20 20 26 30 33 36 38 37

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?